Korean J Hepatol > Volume 6(4); 2000 > Article
The Korean Journal of Hepatology 2000;6(4): 456-467.
원저 / TNM Stage IVa의 진행성 간암에서 간동맥내 항암제 주입약제에 따른 치료성적과 예후인자 ( Treatment Outcome and Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma ( TNM Stage IVa ) according to Anticancer drugs of Transhepatic Arteri
Treatment Outcome and Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma (TNM Stage IVa) according to Anticancer drugs of Transhepatic Arterial Chemoinfusion
Sang Hoon Ahn, M.D., Kwang-Hyub Han, M.D., Young Hoon Youn, M.D.,Myoung Hwan Kim, M.D., Kun Hoon Song, M.D., Kwan Sik Lee, M. D., Chae Yoon Chon, M.D., Young Myoung Moon, M.D., Do Yun Lee, M.D.* and Jong Tae Lee, M.D.*
Department of Internal Medicine, Department of Diagnostic Radiology*, Yonsei University, College of Medicine, Seoul, Korea
ABSTRACT
Background/Aims
The study proposed to evaluate the efficacy of anticancer drugs of intraarterial chemoinfusion and investigate prognostic factors influencing survival. Methods: A total of 127 patients diagnosed as having advanced hepatocellular carcinoma(HCC) of same stage (TNM stage IVa) from 1996 to 1998 were examined. Two intraarterial infusion chemotherapeutic regimens were employed: Adriamycin(Group I) and Cisplatin(Group II). Results: Overall survival was significantly diffrent(10.0 vs 5.7months) and favored Group I. By the univariate analysis, significant prognostic factors included: age, portal vein thrombosis(PVT), size(>5cm) and type of tumor, response rate (size & -fetoprotein) at 3 months after therapy, level of albumin, alkaline phosphatase, and total bilirubin. After repeated therapy, Group I showed better survival (14.0 vs 7.9 months), but there was no statistical difference in survival rate between two groups in the case of large size, PVT, and diffuse type. Conclusion: Group I showed better survival than Group II in advanced HCC of TNM stage IVa. But, considering prognostic factors, there was no significant difference in survival rate between two groups except small size or nodular type of HCC. TNM classification of stage IVa should be reconsidered to include prognostic factors influencing survival rate such as PVT, size and type of HCC.
KeyWords: Neoplasm/ Liver/Hepatocellular carcinoma, Treatment outcome, Prognostic factors, Intraarterial infusion, Neoplasm staging

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 3060
TOTAL : 1739068
Close layer